Connect with us

Investing

AstraZeneca shares fall 3.6% to 7-1/2 week low

Published

on

© Reuters. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

LONDON (Reuters) – Shares in London-listed drugmaker AstraZeneca (NASDAQ:) declined as much as 3.6% on Monday, falling to their lowest since July 19.

Traders attributed the move to a report in the Mail on Sunday newspaper saying the drugmaker’sChief Executive Pascal Soriot had said privately to friends and advisers that he may leave the company as soon as next year.

Reuters could not independently verify the information.

AstraZeneca declined to comment on the report.

Read the full article here

Trending